Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
27.2M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
9.48K
-
Shares change
-
+183
-
Total reported value, excl. options
-
$299K
-
Value change
-
+$5.77K
-
Number of buys
-
1
-
Price
-
$31.53
Significant Holders of Arcturus Therapeutics Holdings Inc. - Common Stock, par value $0.001 per share (ARCT) as of Q4 2023
1 filings reported holding ARCT - Arcturus Therapeutics Holdings Inc. - Common Stock, par value $0.001 per share as of Q4 2023.
Arcturus Therapeutics Holdings Inc. - Common Stock, par value $0.001 per share (ARCT) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.48K shares
of 27.2M outstanding shares and own 0.03% of the company stock.
Largest 10 shareholders include FEDERATED HERMES, INC. (4.71M shares), BlackRock Inc. (2.4M shares), ARK Investment Management LLC (2.05M shares), STATE STREET CORP (1.63M shares), VANGUARD GROUP INC (1.46M shares), Sumitomo Mitsui Trust Holdings, Inc. (1.32M shares), Nikko Asset Management Americas, Inc. (1.32M shares), DIMENSIONAL FUND ADVISORS LP (1.09M shares), Woodline Partners LP (1.07M shares), and FMR LLC (864K shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.